Search results
Results From The WOW.Com Content Network
A specific type of pacemaker, called an implantable cardioverter-defibrillator, combines pacemaker and defibrillator functions in a single implantable device. [5] Others, called biventricular pacemakers, have multiple electrodes stimulating different positions within the ventricles (the lower heart chambers) to improve their synchronization. [6]
An artificial cardiac pacemaker (or artificial pacemaker, so as not to be confused with the natural cardiac pacemaker) or just pacemaker is an implanted medical device that generates electrical impulses delivered by electrodes to the chambers of the heart either the upper atria, or lower ventricles to cause the targeted chambers to contract and ...
The high chance of developing arrhythmias results in up to 25% of patients who have undergone a Senning or Mustard procedure having a pacemaker by adulthood. [ 5 ] Long-term studies have disclosed that although from the functional capacity standpoint the Senning and the Mustard operation are similar, there is a higher risk of sinus node disease ...
Pacemakers are also sometimes used temporarily when someone is recovering from a heart attack or heart surgery, but in this case only the wires are inserted into the body; the pacemaker box stays ...
The main cause of cardiac arrest is two types of arrhythmias called ventricular fibrillation or ventricular tachycardia. ... Endovascular surgery. Coronary artery bypass surgery. ... A pacemaker ...
In the weekly note, the 76-year-old actor shared that he had undergone surgery to have a pacemaker put in, after a lifelong battle with a genetic heart condition."Last Monday, I had surgery to ...
A special pacemaker is implanted to make the skeletal muscle contract. If cardiomyoplasty is successful and increased cardiac output is achieved, it usually acts as a bridging therapy, giving time for damaged myocardium to be treated in other ways, such as remodeling by cellular therapies.
A phase 1 clinical trial is underway (as of August 2009), consisting of patients with coronary artery bypass grafting and patients in end-stage heart failure who have a left ventricular assist device. The trial involves testing a patch called Anginera which contains cells that secrete hormone-like growth factors stimulating other cells to grow.